Monjuvi Injection, Powder, Lyophilized, For Solution
Product Images NDC 50881-013

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Monjuvi (NDC 50881-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Incyte Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (200 mg Vial Carton)

The text provides detailed information about MONJUVI (tafasitamab-cxix) injection for intravenous infusion. It includes instructions on reconstitution, dilution, storage, and administration of the medication. The single-dose vial contains 200 mg of tafasitamab-cxix. It should be stored refrigerated between 36°F to 46°F. This medication is manufactured by Incyte Corporation and is a product of Germany. For complete dosage, storage guidelines, and prescribing information, refer to the packaging or consult a healthcare professional.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.